End-of-day quote
Hong Kong S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
6.06
USD
|
+0.33%
|
|
-0.49%
|
-12.17%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,588
|
4,776
|
4,276
|
-
|
-
|
Enterprise Value (EV)
1 |
11,201
|
4,776
|
3,991
|
4,076
|
3,884
|
P/E ratio
|
-
|
-
|
-
|
-
|
-
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
3.06
x
|
1.01
x
|
0.82
x
|
0.73
x
|
0.64
x
|
EV / Revenue
|
2.72
x
|
1.01
x
|
0.77
x
|
0.69
x
|
0.58
x
|
EV / EBITDA
|
-19.2
x
|
-39.2
x
|
-11.7
x
|
-15.2
x
|
-15.2
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
1.01
x
|
-
|
2.68
x
|
2.59
x
|
2.42
x
|
Nbr of stocks (in thousands)
|
763,025
|
761,500
|
762,156
|
-
|
-
|
Reference price
2 |
16.50
|
6.271
|
5.610
|
5.610
|
5.610
|
Announcement Date
|
15/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
4,119
|
4,712
|
5,196
|
5,896
|
6,670
|
EBITDA
1 |
-583.7
|
-121.8
|
-341
|
-268
|
-255
|
EBIT
1 |
-633.2
|
-174.7
|
-218.7
|
-126
|
-84.92
|
Operating Margin
|
-15.37%
|
-3.71%
|
-4.21%
|
-2.14%
|
-1.27%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/03/23
|
19/03/24
|
-
|
-
|
-
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,388
|
-
|
284
|
200
|
392
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-3.24%
|
3.22%
|
6.5%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
Assets
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
16.30
|
-
|
2.090
|
2.170
|
2.320
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
15/03/23
|
19/03/24
|
-
|
-
|
-
|
Last Close Price
5.61
CNY Average target price
7.893
CNY Spread / Average Target +40.70% Consensus |
1st Jan change
|
Capi.
|
---|
| -12.17% | 592M | | -30.37% | 15.68B | | -22.51% | 12.39B | | -22.88% | 6.74B | | -6.01% | 6.29B | | +11.76% | 6.26B | | +70.00% | 4.95B | | -1.17% | 4.7B | | -5.58% | 4.03B | | -7.87% | 3.62B |
Other Drug Retailers
|